![]() |
CCG-4986
- 英文名称:CCG-4986
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10318
- cas:7134-19-2
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10318 |
用途 | 科研检测 |
英文名称 | CCG-4986 |
包装规格 | 1MG |
CAS编号 | 7134-19-2 |
别名 | CCG-4986 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by TLC,;NMR (Conforms)
分子式:C13H11ClN2O5S2
分子量:374.81
溶剂:DMSO (60 mg/ml) Ethanol (5 mg/ml with warming)
性状:White solid
存储:-20°C
Activity (short version):RGS4 inhibitor
Function / Pharmacology:CCG-4986 is the first selective non-peptide inhibitor of the regulator of G protein signaling protein subtype RGS4.1 It covalently2-3 modifies RGS4 by inhibiting its interaction with Gα (IC50 = 3-5 mM) and suppressing GTPase activity1. Intratympanic administration of CCG-4986 was shown to rescue cochlear injury and hearing loss induced by acoustic overexposure and represents a novel paradigm for the treatment of sensorineural hearing loss via pharmacological regulation of GPCR signaling.4 A novel tool for exploring the involvement of RGS4 in physiological processes.5
分子式:C13H11ClN2O5S2
分子量:374.81
溶剂:DMSO (60 mg/ml) Ethanol (5 mg/ml with warming)
性状:White solid
存储:-20°C
Activity (short version):RGS4 inhibitor
Function / Pharmacology:CCG-4986 is the first selective non-peptide inhibitor of the regulator of G protein signaling protein subtype RGS4.1 It covalently2-3 modifies RGS4 by inhibiting its interaction with Gα (IC50 = 3-5 mM) and suppressing GTPase activity1. Intratympanic administration of CCG-4986 was shown to rescue cochlear injury and hearing loss induced by acoustic overexposure and represents a novel paradigm for the treatment of sensorineural hearing loss via pharmacological regulation of GPCR signaling.4 A novel tool for exploring the involvement of RGS4 in physiological processes.5